Jeanne Shaheen actually said...

There is some disingenuousness in what we are hearing from some of the providers.

Despite the efforts in the last year's legislation, the Inflation Reduction Act to cap out-of-pocket costs for insulin for Medicare, at $35 ...

DOL's role in ensuring that there are enough H-2B visas available to employers is really critical.

we don't have enough H-2B visas in the program.